All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.


Value of Diagnostics in Antimicrobial Stewardship: An Asia-Pacific Outlook

Activity Downloads

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.

Learning Objectives

This program has been designed to meet the educational needs of physicians, pharmacists and other healthcare professionals. At the completion of this activity, the participant will be better able to:

  • Describe evidence-based clinical and laboratory considerations for selecting appropriate antibiotics.
  • Explain the benefits of antimicrobial de-escalation including route and duration.
  • Define diagnostic stewardship, how it’s linked to antimicrobial stewardship and leads to improved patient outcomes.
  • Describe the selection and interpretation of diagnostic tests including traditional and rapid diagnostic assays.


Director, Infectious Disease Research and Training Office, NCID
Senior Consultant, Institute of Infectious Diseases and Epidemiology
Communicable Disease Centre, Dept. of Infectious Diseases
Tan Tock Seng Hospital, Singapore

Deborah Williamson, MD, PhD
Clinical Microbiologist
Associate Professor, University of Melbourne
Deputy Director, MDU PHL
Melbourne, Australia

Moderator: Marnie Peterson, PharmD, PhD
Outreach Coordinator for Antimicrobial Stewardship
Center for Infectious Disease Research and Policy (CIDRAP)
University of Minnesota, USA

CE Accreditation

Release Date: November 5, 2019
Expiration Date: November 5, 2020


This activity is jointly provided by ProCE, Inc. and CIDRAP. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-19-509-H01-P has been assigned to this home study knowledge-based activity (initial release date 11-5-19). This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation to receive pharmacy CE credit. Statements of completion will be issued online at and proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.


AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AKH Inc., Advancing Knowledge in Healthcare designates this on-demand/enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants: NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

Criteria for Success: Statements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form. If you have questions about this CME activity, please contact AKH Inc. at


This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of the content.

Disclosure Declaration

It is the policy of AKH Inc., Advancing Knowledge in Healthcare to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by AKH Inc., Advancing Knowledge in Healthcare prior to accreditation of the activity. AKH staff, reviewers and faculty have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


This CE activity is supported by an educational grant from BioMérieux.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.